Vaughan Nelson Investment Management’s Albany Molecular Research Inc AMRI Stock Holding History

Vaughan Nelson Investment Management’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2,082,900	Closed	-$39.1M	–	193
2016 Q4	$39.1M	Buy	2,082,900 +142,525	+7%	+$2.42M	0.46%	106
2016 Q3	$32M	Buy	1,940,375 +160,450	+9%	+$2.38M	0.38%	115
2016 Q2	$23.9M	Buy	1,779,925 +51,175	+3%	+$747K	0.3%	125
2016 Q1	$26.4M	Buy	1,728,750 +88,025	+5%	+$1.38M	0.33%	120
2015 Q4	$32.6M	Buy	1,640,725 +86,925	+6%	+$1.65M	0.42%	110
2015 Q3	$27.1M	Buy	1,553,800 +57,725	+4%	+$1.18M	0.39%	116
2015 Q2	$30.3M	Buy	1,496,075 +26,575	+2%	+$513K	0.43%	104
2015 Q1	$25.9M	Buy	1,469,500 +131,900	+10%	+$2.25M	0.39%	111
2014 Q4	$21.8M	Buy	+1,337,600	New	+$24.5M	0.32%	119

Other funds holding AMRI

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return

American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return

Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return